Effect of biannual azithromycin on respiratory pathogens among symptomatic children: results from the randomised Macrolides Oraux pour Réduire les Décès avec un Oeil sur la Résistance (MORDOR) I trial.
IF 7.1 2区 医学Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Jie Liu, Stephanie A Brennhofer, Jixian Zhang, Suzanne Stroup, Suporn Pholwat, Ahmed M Arzika, Ramatou Maliki, Amza Abdou, Elodie Lebas, Kieran S O'Brien, Benjamin F Arnold, Jeremy D Keenan, Thomas M Lietman, James A Platts-Mills, Elizabeth T Rogawski McQuade, Eric R Houpt
{"title":"Effect of biannual azithromycin on respiratory pathogens among symptomatic children: results from the randomised Macrolides Oraux pour Réduire les Décès avec un Oeil sur la Résistance (MORDOR) I trial.","authors":"Jie Liu, Stephanie A Brennhofer, Jixian Zhang, Suzanne Stroup, Suporn Pholwat, Ahmed M Arzika, Ramatou Maliki, Amza Abdou, Elodie Lebas, Kieran S O'Brien, Benjamin F Arnold, Jeremy D Keenan, Thomas M Lietman, James A Platts-Mills, Elizabeth T Rogawski McQuade, Eric R Houpt","doi":"10.1136/bmjgh-2024-016043","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Biannual (ie, every 6 months) mass drug administration of azithromycin has reduced childhood mortality in Niger, but its effects on specific respiratory pathogens are not fully elucidated.</p><p><strong>Methods: </strong>Across 2 years of the Macrolides Oraux pour Réduire les Décès avec un Oeil sur la Résistance (MORDOR) study in Niger, we evaluated 1468 nasopharyngeal swabs from children who presented for care with respiratory symptoms. Swabs were tested by quantitative PCR using a customised TaqMan Array Card that included assays for 19 respiratory pathogens.</p><p><strong>Results: </strong>Nasopharyngeal detection of <i>Haemophilus influenzae</i>, <i>Moraxella catarrhalis</i> and <i>Streptococcus pneumoniae</i> was common in both azithromycin and placebo communities. The prevalence was reduced in children from azithromycin communities for just two pathogens: <i>Bordetella pertussis</i> and <i>H. influenzae</i> type b (Hib). These children had a 49% and 65% reduction in the prevalence of <i>B. pertussis</i> and Hib in nasopharyngeal swabs, respectively, compared with children from the control communities (prevalence ratios 0.51, 95% CI 0.35, 0.75; and 0.35, 95% CI 0.17, 0.71).</p><p><strong>Conclusions: </strong>Biannual administration of azithromycin to communities in Niger was associated with lower prevalence of <i>B. pertussis</i> and Hib compared with placebo. These reductions may explain some of the childhood mortality benefit of azithromycin.</p><p><strong>Trial registration number: </strong>NCT02048007.</p>","PeriodicalId":9137,"journal":{"name":"BMJ Global Health","volume":"10 2","pages":""},"PeriodicalIF":7.1000,"publicationDate":"2025-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11815404/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Global Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/bmjgh-2024-016043","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Biannual (ie, every 6 months) mass drug administration of azithromycin has reduced childhood mortality in Niger, but its effects on specific respiratory pathogens are not fully elucidated.
Methods: Across 2 years of the Macrolides Oraux pour Réduire les Décès avec un Oeil sur la Résistance (MORDOR) study in Niger, we evaluated 1468 nasopharyngeal swabs from children who presented for care with respiratory symptoms. Swabs were tested by quantitative PCR using a customised TaqMan Array Card that included assays for 19 respiratory pathogens.
Results: Nasopharyngeal detection of Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pneumoniae was common in both azithromycin and placebo communities. The prevalence was reduced in children from azithromycin communities for just two pathogens: Bordetella pertussis and H. influenzae type b (Hib). These children had a 49% and 65% reduction in the prevalence of B. pertussis and Hib in nasopharyngeal swabs, respectively, compared with children from the control communities (prevalence ratios 0.51, 95% CI 0.35, 0.75; and 0.35, 95% CI 0.17, 0.71).
Conclusions: Biannual administration of azithromycin to communities in Niger was associated with lower prevalence of B. pertussis and Hib compared with placebo. These reductions may explain some of the childhood mortality benefit of azithromycin.
期刊介绍：
BMJ Global Health is an online Open Access journal from BMJ that focuses on publishing high-quality peer-reviewed content pertinent to individuals engaged in global health, including policy makers, funders, researchers, clinicians, and frontline healthcare workers. The journal encompasses all facets of global health, with a special emphasis on submissions addressing underfunded areas such as non-communicable diseases (NCDs). It welcomes research across all study phases and designs, from study protocols to phase I trials to meta-analyses, including small or specialized studies. The journal also encourages opinionated discussions on controversial topics.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
